Financials
- Market Capitalization 301.1 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3116 | EBS Emergent BioSolutions Inc. Common Stock | 7.51 USD | -6.24% | -7.74% | -10.27% | -29.94% | 387.49 M USD | ||
| 3140 | AKBA Akebia Therapeutics, Inc. - Common Stock | 1.40 USD | +1.45% | +3.70% | +50.54% | +18.64% | 375.56 M USD | ||
| 3371 | TKNO Alpha Teknova, Inc. - Common Stock | 5.41 USD | 0.00% | +1.31% | +28.81% | +21.30% | 290.05 M USD | ||
| 3492 | SIGA SIGA Technologies Inc. - Common Stock | 3.42 USD | -5.26% | -6.56% | -21.20% | -59.76% | 245.30 M USD |
Frequently asked questions about Organogenesis Holdings Inc. - Class A
What is the Organogenesis Holdings Inc. - Class A stock price today?
The current price of Organogenesis Holdings Inc. - Class A (ORGO) is 2.34. Over the past 24 hours, the stock has changed by +3.08%. Follow the ORGO chart for real-time price dynamics.
What is the stock ticker of Organogenesis Holdings Inc. - Class A?
Organogenesis Holdings Inc. - Class A trades under the ticker ORGO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Organogenesis Holdings Inc. - Class A stock going up?
ORGO has changed by -5.26% over the last week, -2.09% over the last month, and -45.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Organogenesis Holdings Inc. - Class A net income for the last quarter?
Organogenesis Holdings Inc. - Class A reported net income of -53.16 M for the last quarter. The previous quarter showed 43.7 M, which means net income changed by -221.64%.
How many employees does Organogenesis Holdings Inc. - Class A have?
As of the latest available data, Organogenesis Holdings Inc. - Class A has 854 employees. Workforce size can provide additional context about the company's scale and operations.
What is Organogenesis Holdings Inc. - Class A EBITDA?
Organogenesis Holdings Inc. - Class A EBITDA is -60.76 M, and its EBITDA margin is -163.21%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Organogenesis Holdings Inc. - Class A stock?
You can buy Organogenesis Holdings Inc. - Class A (ORGO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Organogenesis Holdings Inc. - Class A stock?
Investing in Organogenesis Holdings Inc. - Class A requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ORGO chart and related analysis on metatrader.com as part of your research.